The FDA approved Itvisma gene therapy for patients aged 2 years and older with spinal muscular atrophy and confirmed SMN1 ...

Nutritional issues such as ARFID are highly prevalent among patients with SSc and can lead to poor outcomes and other ...

Patients with SARDs face an increased risk for hospitalization during RSV infection, with greater risk linked to frailty, concurrent infection, and higher comorbidity burden.

The World Health Organization emphasized early diagnosis, integrated care, and long-term GLP-1 use for adults with obesity.

The WHO warned progress against measles was at risk due to missed vaccines and recovery lags in disease-tracking systems since the pandemic.

An online self-referral tool for patients with chronic back pain showed feasibility for identifying axial spondyloarthritis.

An unreleased FDA memo claimed the COVID-19 vaccine may have been a factor in 10 pediatric deaths, possibly from myocarditis.

Concomitant inflammatory bowel disease (IBD) negatively affects disease control and treatment response among patients with psoriatic arthritis (PsA) receiving biologic therapy, according to study ...

Voyxact, an APRIL inhibitor, receives FDA accelerated approval for adults with primary IgA nephropathy to reduce proteinuria.

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.

Standard population-based cardiac screening tools often failed to identify younger patients at risk for a first myocardial infarction.

Patients with gout receiving oral ULT showed similar rates of MSU crystal dissolution in the joints and tendons.